PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) Form 10-Q Quarterly Reports
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) is a publicly traded company on the Nasdaq, categorized under SIC 3826 (Laboratory Analytical Instruments). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PACB
CIK: 1299130
Exchange: Nasdaq
SIC 3826: Laboratory Analytical Instruments
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerYogesh Ransing
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-08 | 2026-10-06 | FORM 4 | 0001384133-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-10-06 | — | 144 Filing | 0001950047-26-010078 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0001299130-26-000128 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001950047-26-008204 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-096937 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | FORM 4 | 0001299130-26-000126 | View SEC Doc Filr Page |
| S-8 | 2026-08-07 | — | S-8 | 0001299130-26-000124 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001299130-26-000122 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-07-30 | 8-K | 0001299130-26-000117 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-08 | 8-K | 0001299130-26-000111 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | FORM 4 | 0001299130-26-000108 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | FORM 4 | 0001299130-26-000106 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | FORM 4 | 0001299130-26-000104 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | FORM 4 | 0001299130-26-000102 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | FORM 4 | 0001299130-26-000100 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | FORM 4 | 0001299130-26-000098 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | FORM 4 | 0001299130-26-000096 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | FORM 4 | 0001299130-26-000094 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | 8-K | 0001299130-26-000092 | View SEC Doc Filr Page |
| SD | 2026-05-27 | — | SD | 0001299130-26-000088 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-22 | — | DEFA14A | 0001299130-26-000084 | View SEC Doc Filr Page |
| 10-Q | 2026-05-08 | 2026-03-31 | 10-Q | 0001299130-26-000081 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001299130-26-000076 | View SEC Doc Filr Page |
| ARS | 2026-04-23 | 2025-12-31 | ARS | 0001299130-26-000067 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-23 | — | DEFA14A | 0001299130-26-000065 | View SEC Doc Filr Page |